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Background: A recently published transcript set is suitable for gene expression-based discrimination of normal
colonic and colorectal cancer (CRC) biopsy samples. Our aim was to test the discriminatory power of the
CRC-specific transcript set on independent biopsies and on formalin-fixed, paraffin-embedded (FFPE) tissue
samples.
Methods: Total RNA isolations were performed with the automated MagNA Pure 96 Cellular RNA Large
Volume Kit (Roche) from fresh frozen biopsies stored in RNALater (CRC (n = 15) and healthy colonic (n = 15)),
furthermore from FFPE specimens including CRC (n = 15) and normal adjacent tissue (NAT) (n = 15) specimens
next to the tumor. After quality and quantity measurements, gene expression analysis of a colorectal
cancer-specific marker set with 11 genes (CA7, COL12A1, CXCL1, CXCL2, CHI3L1, GREM1, IL1B, IL1RN, IL8, MMP3,
SLC5A7) was performed with array real-time PCR using Transcriptor First Strand cDNA Synthesis Kit (Roche)
and RealTime ready assays on LightCycler®480 System (Roche). In situ hybridization for two selected
transcripts (CA7, CXCL1) was performed on NAT (n = 3), adenoma (n = 3) and CRC (n = 3) FFPE samples.
Results: Although analytical parameters of automatically isolated RNA samples showed differences between
fresh frozen biopsy and FFPE samples, both quantity and the quality enabled their application in gene
expression analyses. CRC and normal fresh frozen biopsy samples could be distinguished with 93.3 %
sensitivity and 86.7 % specificity and FFPE samples with 96.7 and 70.0 %, respectively. In situ hybridization
could confirm the upregulation of CXCL1 and downregulation of CA7 in colorectal adenomas and tumors
compared to healthy controls.
Conclusion: According to our results, gene expression analysis of the analyzed colorectal cancer-specific
marker set can also be performed from FFPE tissue material. With the addition of an automated workflow,
this marker set may enhance the objective classification of colorectal neoplasias in the routine procedure in
the future.
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Colorectal cancer (CRC) is one of the leading malig-
nant neoplasms worldwide, and early diagnosis and
molecular characterization is considered essential to
decrease CRC-related deaths [1]. A discriminatory set
of transcripts was recently identified that proved to be
suitable for distinguishing CRC from normal colon
with high sensitivity and specificity [2]. The study used
53 biopsies fresh frozen colon samples along the
dysplasia-carcinoma transition containing CRC (n =
22), adenoma (n = 20) and 11 healthy colon (n = 11)
specimens, and a qPCR-based expression profile (tran-
script set) was identified that discriminated the malig-
nant from benign colon.
Although the best specimens for gene expression ana-
lysis are fresh frozen tissue samples stored with or with-
out stabilization reagents (e.g. RNA Stabilization
Reagent) with highly intact RNA content, difficulties and
disadvantages of fresh frozen specimen collection (as re-
quiring special logistic issues, equipment and hands-on
time) can limit the number of fresh frozen samples in
certain hospitals. In parallel, formalin-fixed, paraffin-
embedded (FFPE) tissue samples are routinely collected
for diagnostic purpose and are stored at room
temperature in archives for several years. Diagnosis of
colorectal diseases are commonly made on the basis of
histology of stained slides from FFPE biopsies or bigger
removed tissue samples taken during routine endoscopy
examination or surgery. The fixation in formalin con-
serves the tissue structure, but holds technical disadvan-
tages in terms of molecular sample quality, such as
nucleic acid degradation and crosslink formation; this
renders it a sub-optimal sample source [3, 4]. In order
to optimize sample quality from FFPE tissue samples,
manual and automated nucleic acid isolation kits and
FFPE-optimized protocols are continuously being devel-
oped, that can also enhance the use of FFPE samples in
gene expression studies, as well [5–7]. Automated nucleic
acid isolation systems hold the possibility to remarkably
increase the throughput of diagnostic laboratories. Fur-
thermore, automated protocols have the advantage of
standardization, minimal hands-on time that is crucial in
studies with high sample numbers [8].
Although molecular characterization of homogenized
tissue samples serves information about the whole
tumor mass, up- or downregulation of genes can be
characteristic for some certain tumor areas or cell types
[9]. In situ analysis can broaden our knowledge by pro-
viding information about tumor heterogeneity, as well as
the localization of the altered mRNA expression.
As a validation study, we aimed to extend the analysis
of the previously published CRC-specific marker set on
FFPE samples. The applicability of this marker set was
tested on 30 independent fresh frozen biopsy samples(CRC: n = 15; healthy colon: n = 15) and also on 30
formalin-fixed, paraffin-embedded (FFPE) tissue samples
(CRC: n = 15; healthy colon: n = 15) after RNA isola-
tion with an automated method. Furthermore, in situ
hybridization was performed on 9 FFPE samples (CRC:
n = 3; adenoma: n = 3; healthy colon: n = 3).
Methods
Patients and sample collection
Biopsy samples (approx. 5 mg tissue) were collected dur-
ing routine endoscopy from patients scheduled for
screening colonoscopy including untreated colorectal
cancer (CRC) cases and healthy donors (n = 30; 15 CRC,
15 N). Biopsies were snap frozen and stored in RNALa-
ter at -80 °C. Independent formalin-fixed, paraffin-
embedded (FFPE) tissue blocks of surgically removed
CRC (UICC stage II-III) and corresponding normal adja-
cent (NAT) tissue specimens (n = 30; 15 CRC, 15 NAT)
from the same patients were collected from a regional
pathology archive. For in situ hybridization analysis
NAT (n = 3), adenoma (n = 3) and CRC (n = 3) FFPE
samples were used. No more than 6 months old FFPE
blocks were used for RNA isolation. Written informed
consent was obtained from all patients and donors. The
study was approved by the local ethics committee (Sem-
melweis University Regional and Institutional Commit-
tee of Science and Research Ethics; Nr.: ETT TUKEB
23970/2011).
RNA isolation
Fresh frozen biopsy samples in RNALater were thawed
on ice and were transferred into MagNALyser Green
Bead tubes containing ceramic beads and 800 μl MagNA
Pure LC RNA Isolation Tissue Lysis Buffer (Roche Ap-
plied Science, Penzberg, Germany). All of the colorectal
cancer samples contained tumor cell percentage higher
than 80 %. No macrodissection was made prior to RNA
isolations. Tissue samples were homogenized using
MagNALyser instrument with 6500 rpm for 50 s twice.
Ten micrometer thick sections were cut from the FFPE
blocks; and each section was transferred into a micro-
centrifuge tube. Deparaffinization was performed with
1 ml xylene, incubating twice for 10 min, and 1 ml abso-
lute ethanol also incubating twice for 10 min. Total
RNA isolation was performed from 350 μl biopsy lysates
and from each air dried deparaffinized section with the
automated MagNA Pure 96 Cellular Large Volume Kit
(Roche) on the MagNA Pure 96 nucleic acid isolation
system according to the manufacturer’s instructions.
Quantitative and qualitative analysis of the isolated RNA
samples
RNA concentration and purity ratios (OD260/280,
OD260/230) were measured with NanoDrop 1000
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Waltham, USA). RNA quality was assessed using the
RNA Integrity Number (RIN) measured by RNA 6000
Pico LabChip kit on a microcapillary electrophoresis
system (Agilent BioAnalyzer 2100).
Real-time PCR analysis
Using the Transcriptor First Strand cDNA Synthesis Kit
(Roche Diagnostics), 150 ng of total RNA was reverse
transcribed with the combination of anchored-oligo(dT)
and random hexamer primers included in the kit (Cat
no: 04897030001). Gene expression analysis was per-
formed for eleven colorectal cancer specific markers [2]
(CA7, COL12A1, CXCL1, CXCL2, CHI3L1, GREM1,
IL1B, IL1RN, IL8, MMP3, SLC5A7) and 18S ribosomal
RNA endogenous control (Table 1). RealTime ready as-
says from Universal Probe Library (Roche Applied Sci-
ence) were used with forward and reverse primers (400
nM) and fluorescently labeled hydrolysis probes (200
nM) lyophilized into 384 well plates (Table 1). Real-time
polymerase chain reaction analysis were performed in a
final volume of 10 μl using 5 ng cDNA/well and 5 μl
LightCycler® 480 Probes Master. The reagents and the
samples were pipetted by epMotion 5070 liquid handling
robot (Eppendorf ). Thermal cycling conditions on the
LightCycler® 480 System were the following: enzyme ac-
tivation: 95 °C for 10 min, 45 cycles of amplification:
95 °C for 10 s, 60 °C for 30 s and signal detection at 72 °C
for 1 s and cooling at 40 °C for 30 s. For data
normalization 18S endogenous control was used.
For receiver operating characteristic (ROC) curve ana-
lysis, MedCalc13.3 software was applied to evaluate theTable 1 CRC-specific transcript set [2]




CA7 carbonic anhydrase VII 77 103015
CHI3L1 chitinase 3-like 1 76 103035
COL12A1 collagen, type XII, alpha 1 66 103045
CXCL1 chemokine (C-C-C motif)
ligand 1
105 105522
CXCL2 chemokine (C-C-C motif)
ligand 2
95 103070
GREM1 gremlin 1 111 103109
IL1B interleukin 1, beta 87 100950
IL1RN interleukin 1 receptor
antagonist
76 103133
IL8 interleukin 8 92 103136
MMP3 matrix metallopeptidase 3 110 103167
SLC7A5 solute carrier family 7,
member 5
72 103210
RN18S1 RNA, 18S ribosomal 1,
18S ribosomal RNA
73 104092discriminatory power of the examined genes. Interactive
dot diagrams represent differences on a scale and indi-
cate specificity and sensitivity values of the analyzed
markers. For discriminant analysis SPSS 22.0 software
was applied.
In situ RNA hybridization
In situ analysis was performed on two of the eleven
markers. CA7 was selected as it was the only downregu-
lated transcript along CRC formation, while among the
upregulated transcripts CXCL1 was included in the ex-
periment, as it showed remarkable protein expression
level changes between normal and CRC samples [10].
For both human CA7 mRNA (NM_005182.2) and
CXCL1 mRNA (NM_001511.2), two non-overlapping
oligonucleotide sequences were identified: for CA7
mRNA: 5’-TGGCATTCCAGTGAACCAGAT-3’(nucleo-
tides 643-623) and 5’-AGCGCATCTGTCAGACGAT
TCAT-3’ (nucleotides 758-736), and for CXCL1 mRNA:
5’-ATGCAGGATTGAGGCAAGCTTT-3’ (nucleotides
347-326) and 5’-TTGGATTTGTCACTGTTCAGCAT-3’
(nucleotides 399-377). Locked nucleic acid (LNATM)
oligonucleotides were designed resulting in RNA Tm’s
of 87 °C, 84 °C, 85 °C, 86 °C, respectively. In addition,
we included a negative control probe: Scramble 22’mer
LNA oligo (RNA Tm 87 °C), and a positive control
LNA probe against miR-126 (21’mer, RNA Tm 84 °C),
see Jørgensen and collaborators, 2011 [11]. All LNA
oligonucleotides were 6-carboxyfluorescein (FAM)-la-
beled at the 5’- and 3’-ends (double-FAM labeled
probes) and obtained from Exiqon, Vedbæk, Denmark.
In situ hybridization was performed using a TecanGen-
epaint in situ hybridization instrument (Tecan, Män-
nedorf, Switzerland) essentially as described elsewhere
[12]. In brief, 6 μm thick tissue sections from normal
colon, colon adenomas and cancers, were deparaffi-
nized and pretreated with proteinase-K (25 μg/ml for
8 min at 37 °C). In situ hybridization was performed
by incubating the two double-FAM labeled CA7 and
CXCL1 LNA probes mixed at 60 nM diluted in Exiqon
hybridization buffer (Exiqon, Vedbæk, Denmark) at
57 °C for 1 h. Double-FAM labeled scramble (60 nM)
and miR-126 (at 30 nM) probes were used as negative
and positive controls, respectively. After stringent
washes in SSC buffers, the sections were incubated
with alkaline phosphatase–conjugated anti-FAM
(1:800, Roche, Mannheim, Germany). Slides were de-
veloped in 4-nitro-blue tetrazolium (NBT) and 5-
brom-4-chloro-3’-Indolyl-phosphate (BCIP) substrate
(Roche) for 90 min resulting in a dark-blue precipitate.
Slides were counter stained with Nuclear Fast Red (Vec-
tor Laboratories, Burlingname, CA). The slides were ex-
amined from digital whole slides obtained with
3DHISTECH scanner using a 20x objective.
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Quantity and quality of the isolated RNA samples
We first isolated total RNA from 30 fresh frozen colonic
endoscopy samples and from 30 FFPE resection samples
with MagNA Pure 96 automated protocol and the yields,
purity and integrity were compared. Yields of RNA iso-
lated from fresh frozen samples and FFPE sections were
found to be similar (Mean ± SD; fresh frozen: normal =
5.98 ± 1.72 μg, tumor = 5.77 ± 2.27 μg FFPE: normal =
4.20 ± 3.70 μg, tumor = 7.10 ± 3.30 μg) (Fig. 1a). Both
OD260/280 and OD260/230 ratios were significantly
higher (p < 0.001) in fresh frozen tissue samples com-
pared to FFPE samples (Fig. 1b, 1c). Thus, as expected,
the RNA purity ratios were found to be lower in RNA
eluates isolated from FFPE samples than from frozen
samples. RNA Integrity Numbers (RIN) were automatic-
ally generated by the software algorithm on the basis of
the sample’s electropherogram and indicates the integrity
of the total RNA on a scale from 1 to 10. The RINsFig. 1 Analytical parameters of the automatically isolated RNA samples. a R
number (RIN) of normal and tumor fresh frozen biopsy and FFPE samples.
on the boxplots, while boxes indicate median and standard deviation of thwere found to be significantly higher in the fresh frozen
biopsy samples (normal = 7.87 ± 0.5; tumor = 7.55 ± 0.94)
compared to FFPE samples (normal fresh frozen biopsy =
2.60 ± 1.20; tumor fresh frozen biopsy = 2.40 ± 0.50),
(p < 0.001) (Fig. 1d).
Gene expression analysis
Gene expression analysis of eleven CRC-specific markers
was performed in order to test the performance of the
isolated samples in real-time PCR reactions. Unsuper-
vised hierarchical clustering revealed two major clusters
in fresh frozen biopsy samples, one cluster with fresh
frozen CRC cases with one misclassified normal case
and another major cluster containing normal (14/15)
and misclassified CRC cases (8/15) (Fig. 2a). In contrast,
an almost clear separation of formalin-fixed, paraffin
embedded colorectal cancer and normal colonic FFPE
sample clusters could be found, only two CRCs were
misclassified in the normal cluster (Fig. 2b).NA yield (μg RNA); b) OD260/280; c) OD260/230 and d) RNA integrity
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Fig. 2 Heat maps of real-time PCR data representing gene expression alteration of the 11 analyzed transcripts in (a) fresh frozen biopsyand (b)
FFPE samples. Color scale encodes relative overexpression (red) to underexpression (green)
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fresh frozen biopsy and FFPE samples
Discrimination analysis was performed in order to test the
classificatory power of the transcript set (Fig. 3) on inde-
pendent fresh frozen biopsy and FFPE samples. In biopsy
samples, the set could correctly classify the original groupedFig. 3 Discriminant analysis of (a) fresh frozen biopsy and (b) FFPE samples
contains predicted group membership data on the original grouped casescases (100 %; 100 % respectively), while 93.3 % of cross vali-
dated grouped cases were correctly classified (Fig. 3a). From
the FFPE sample set 6 normal and 8 tumor samples were
automatically excluded in the discrimination analysis. The
remaining 9 normal and 7 tumor samples could be classified
correctly (100 %; 100 % respectively) (Fig. 3b).on the basis of gene expression levels of 11 transcripts. The table
and on the cross validated samples
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Paired comparison was performed with receiver oper-
ating characteristic (ROC) analysis in order to test
the sensitivity and specificity of the transcript set on
independent samples. Sensitivity and specificity were
calculated from gene expression of the 11 discrimin-
atory marker with the same equation that was estab-
lished on the basis of multiple logistic regression on
the original biopsy samples described in the recent
manuscript about the marker set [2]. Normal and
fresh frozen CRC samples could be distinguished by
93.3 % sensitivity and 86.7 % specificity (Fig. 4a). Nor-
mal and CRC FFPE tissue samples could be discrimi-
nated with higher specificity (96.7 %) and but with
lower sensitivity (70.0 %) (Fig. 4b).
In situ hybridization
In situ hybridization was performed for CA7 and CXCL1,
the two selected markers from the CRC-specific transcript
set. CA7 was selected as the only downregulatedFig. 4 Interactive dot diagram of (a) fresh frozen biopsy and (b) FFPE samp
of the previously published transcript set, a multiple logistic regression equ
visualized on interactive dotblots, normal and tumor groups are displayed
cut off point with the best sensitivity and specificity results. The sensitivity
beside the dotblotstranscript along CRC formation, while CXCL1 was in-
cluded in the experiment, as it showed remarkable protein
expression level changes between normal and CRC sam-
ples [10]. In a pilot experiment, the CA7 and CXCL1
probes were tested in various colon lesions. The probes
incubated individually resulted in weak cellular staining
with diffuse background, whereas the probes incubated in
a mix resulted in a more robust signal with a better
signal-to-noise ratio (data not shown). From three pa-
tients, we then examined paraffin samples from normal
colon, adenoma and adenocarcinoma. All three FFPE
adenocarcinoma specimens contained parts of luminal ul-
ceration and invasive front. A weak distinct CA7 ISH sig-
nal was identified with the CA7 probe set in a subset of
epithelial cells in all three normal colonic samples (Fig. 5).
No CA7 ISH signal was detected in adenoma and colon
cancer tissue. In the three cases of colon cancer examined,
the CXCL1 ISH signal was seen in a subset of stromal
cells located towards the central ulcer of the lesion (Fig. 5i).
The stromal localization and the distribution patternles according to the multiple logistic regression equation. On the basis
ation was applied to the present study’s results. The results can be
as dots in two separate groups and the horizontal line indicates the
and specificity values are calculated by the algorithm, that can be seen
Fig. 5 In situ hybridization for CA7 and CXCL1 mRNAs. Paraffin sections from normal colon (a-d), colon adenoma (e-h) and colon cancer (i-l)
were stained with LNA probes for CXCL1 mRNA (a,e,i), CA7 mRNA (b,f,j), a generic unspecific sequence, scramble (c,g,k), and a positive control
probe, miR-126 (d,h,l). The CXCL1 ISH signal is seen in a population of macrophage-like cells located in the cancer stroma (i, arrows) just below
the luminal ulceration (indicated by U), whereas no CXCL7 ISH signal is detected in the normal colon mucosa and in the adenoma (a,e). The CA7
ISH signal is seen in a subset of epithelial cells in normal colon mucosa (b, arrows), whereas no ISH signal is detected in the colon adenoma and
cancer tissue (f,j). miR-126 ISH signal is prevalent in endothelial cells (arrows in d,h,l), and only background staining is seen with scramble probe
(c,g,k). Tissue sections were counter stained with Nuclear Fast Red. 50 μm bar is representative for all images
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a subset of macrophages. No CXCL1 ISH signal was de-
tected in normal colon and in the colon adenomas.
Discussion
Conventional tumor classification based on histopath-
ology is likely to be accompanied by molecular biology
methods in the future. In order to determine the ap-
plicability of a previously identified colorectal cancer-
specific transcript set, gene expression of these markers
were analysed on independent fresh frozen and also on
FFPE samples. Furthermore, as methods enhanching diag-
nostic approaches are required to have straightforward
workflow, automated RNA isolation and automated poly-
merase chain reaction setup were also integrated in the
study.
The present study aimed to test the discriminatory
power of a set of 11 transcripts. According to our results
this mRNA transcript set could be suitably applied even
on FFPE samples with relatively high sensitivity and spe-
cificity. Based on the expression level of the transcript
set, independent fresh frozen biopsy samples could be
classified correctly in original grouped cases (100 %;
100 %, respectively), while 93.3 % of cross validated
grouped cases were correctly classified. The aim of thisstudy was to confirm the possibility of discriminating
FFPE samples by using mRNA markers. Although only a
relatively low sample set was analyzed, an almost clear
separation of normal vs. CRC FFPE samples could be
achieved with unsupervised hierarchical clustering.
Analytical parameters of total RNA samples isolated
from different sample sources can be critical regarding
downstream molecular analyses. In our study yield of
RNA isolated from FFPE and fresh frozen samples were
found to be similar, which is in accordance with litera-
ture data [13]. In our analysis altogether 150 ng of total
RNA was enough to analyze gene expression of 11 se-
lected transcripts and an endogenous control on a cus-
tom made pre-lyophilized real-time PCR plate. As it can
be expected according to previous methodical studies
[14, 15], RNA purity ratios were found to be lower in
RNA eluates isolated from FFPE samples and RIN was
significantly higher (p < 0.001) in fresh frozen biopsies.
However, the majority of the FFPE reactions had similar
results as the fresh frozen samples and only three out of
11 assays showed higher presence of failed PCR reac-
tions with FFPE samples. The use of even shorter ampli-
con sizes might result in successful reactions [16].
It is well known and documented, that colorectal can-
cer development is accompanied with gene expression
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explore whole genome gene expression profiles of CRC
cases attempting to identify clinically useful markers
[18–20] and part of these projects focused on the dis-
covery of altered gene expression patterns between nor-
mal colon mucosa and tumor tissue samples revealing
different CRC-specific transcript sets [21–24]. Among
the firsts, in 1999 Alon and collaborators identified a set
of 2000 transcripts clustering 22 normal and 30 colorec-
tal cancer tissue samples with highest minimal intensity
across the samples [25]. Later, it was followed by subse-
quent studies reporting more restricted potential marker
sets. For example, on the basis of Zou and collaborators’
results analyzing normal (n = 8) and CRC (n = 9 CRC)
fresh frozen samples 250 differentially expressed tran-
scripts could be identified [26]. Lin and colleagues exam-
ined normal (n = 20), adenoma (n = 9) and CRC (n = 11)
fresh frozen tissue samples and could define 427 dis-
criminatory markers [27]. Friederichs and collaborators
identified 330 transcripts on the basis of gene expression
data of CRC (n = 25) and normal (n = 6) colorectal fresh
frozen tissue samples [28].
The comparison of gene expression profiling studies
focusing on colorectal cancer development remains chal-
lenging. According to a recent systematic review of 23
independent expression analyses revealed only 54 genes,
reported from at least two studies, showing the same ex-
pression alteration direction [29]. Furthermore, despite
of the known molecular complexity underlying this dis-
ease, studies have been largely focused on the identifica-
tion of single markers (e.g. upregulated IL8, AXIN2,
CXCL12, CDK8; downregulated CA2, COL1A2, FABP1,
IGFBP7) [30].
However, in order to achieve higher sensitivity and
specificity multimarker sets should be analyzed, these
are considered to be superior to single marker discrim-
inations (Grabowski [31]). The sensitivity and the spe-
cificity of the transcript set [2] published by Galamb
and colleagues in 2012 were assessed by discriminant
analysis revealing 93.3 % sensitivity and 86.7 % specifi-
city in fresh frozen biopsies and 96.7 % sensitivity and
70 % specificity in FFPE samples.
On the basis of Garcia-Bilbao and collaborators work
published in 2012, relatively higher discriminating power
of non-tumoral vs. CRC fresh frozen biopsy samples
could be achieved on the basis of a set of 7 transcripts
(ENC1, ACAT1, TMEM132A, CMTM7, FAM60A,
MADCAM1, DDX55) with RT-qPCR with 90.9 % sensi-
tivity and 100 % specificity [32]. Another study reported
83.3 % specificity and 70.8 % sensitivity in tumor vs. nor-
mal FFPE tissue classification by a prognostic marker set
(with not only mRNA markers: neuroendocrine differen-
tiation, overexpression of the sialyl-Lex antigen, overex-
pression of the peripheral benzodiazepine receptor(PBR), BAX protein expression and p53 mutational sta-
tus) [31].
In situ analysis of two transcripts of the analyzed set
showed the same gene expression alteration tendency, as
found in RT-PCR experiments. CA-7 was found to be
downregulated showing weak CA7 ISH signal in normal
colon and no detectable signal in the analyzed aden-
omas and colon cancer FFPE tissue samples. In con-
trast, chemokine (C-X-C motif ) ligand 1 was found to
be upregulated according to our RT-PCR results. With
in situ mRNA hybridization CXCL1 was also found to
be an upregulated transcript in colorectal cancer FFPE
tissues, with no CXCL1 ISH signal in the healthy and
adenomatous colon tissue specimens. Interestingly,
CXCL1 transcript could be localized in stromal cells to-
wards the ulcerous areas of the tumors.
The ratio of failed reactions with FFPE samples were
more abundant with some assays (MMP3, CA7, IL8)
(Additional file 1: Table S1), that might be due to technical
reason, e.g. relatively longer amplicon sizes (MMP3:
110 bp; IL8: 92 bp; Table 1) compared to the other as-
says or the presence of contaminants in RNA samples
isolated from FFPE tissue samples. Furthermore, failed
reactions might indicate biological reason in the back-
ground, e.g. possible downregulation of CA7 in CRC
samples and low MMP3 expression in normal colon
samples.
The majority of the transcripts (10 from the 11
markers) analyzed in this study was found to be upregu-
lated along colorectal cancer formation also in fresh fro-
zen and in FFPE tissue samples. On the other hand,
gene expression alterations observed in our RT-PCR ex-
periments of the 11 transcripts have already been re-
ported in the literature. Interleukin 1 beta (IL1B) is
proven to promote the invasiveness of malignant cells
and this pro-inflammatory cytokine is required for
angiogenesis [33]. The -31 T/C polymorphism of this
gene is associated with colorectal cancer risk, as IL-1B-
511 heterozygotes and T carriers has reduced risk of
colorectal carcinoma development [34] and it is associ-
ated with the recurrence of CRC [35]. IL-1B is involved
in the survival and proliferation of remnant cancer cells
after tumor resection in colorectal carcinoma [36].
IL1RN polymorphism is also associated with CRC [37].
Interleukin 8 (IL8) overexpression has been docu-
mented in CRC; it is involved in proliferation, metas-
tasis and angiogenesis, furthermore its knock down
can inhibit colorectal cancer cell growth and metasta-
sis formation [38, 39]. Gremlin -1 overexpression has
been detected in various cancer types including pan-
creas, breast, kidney, ovary and colorectal cancer [40].
Secretion of gremlin-1 protein can enhance tumori-
genesis via enhancing cell proliferation [41]. CXCL2
(alias Gro2) shows elevated expression in colorectal
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[42] and it could accelerate tumor cell growth by in-
ducing cell proliferation in a mouse implantation
model [43]. Collagen type XII (COL12A1) was re-
cently identified as a marker of myofibroblastic differ-
entiation in CRC in the desmoplastic invasion fronts
of the tumors [44]. Its overexpression could be de-
tected in CRC-associated CAF (cancer-associated
fibroblast) cells isolated from a mouse model of human
sporadic cancer [45]. Chitinase 3-like 1 (CHI3L1, alias
HCgp39 or YKL-40) is a secreted glycoprotein that is not
synthesized physiologically, but in inflammatory and
cancerous states [46, 47], it proved to have an import-
ant role in macrophage recruitment and angiogenesis
during colorectal cancer formation [48]. According to
a recent report, this marker can be usefully utilized in
monitoring CRC-patients in the follow-up phase, as el-
evated serum YKL-40 levels is associated with short
survival time [49]. Solute carrier family 7, member 5
was found to be upregulated 3-fold in the adenoma
and 5-fold in CRC cases on the protein level [50].
Carbonic anhydrase 7 (CA7) plays role in acid-base
balance, bone restoration, respiration, calcification and
catalyze zinc2+ ion dependent hydration of CO2 [51].
According to a recently published manuscript from
Yang and collaborators analyzing FFPE (n = 379) and
fresh frozen CRC (n = 84) tissue samples, CA7 was
frequently downregulated in tumor samples both on
mRNA and protein levels. Furthermore, authors could
correlate decreased CA7 expression levels with shorter
disease-free survival time [52]. Downregulation of
CA7 transcript along tumor formation and the pres-
ence of a large CpG island in the gene’s promoter re-
gion raises the theoretical possibility of its epigenetic
gene regulation by DNA methylation; further studies
are needed to confirm this hypothesis. According to
the in situ hybridization results the extent of CA7
expression level alteration was lower than observed
in RT-PCR experiments. However, CA7 expression
levels were confirmed to be different between healthy
and diseased colon samples according to the RT-PCR
results.
CXCL1 (Groα) gene encodes a secreted interleukine-
like molecule binding specifically to G-protein-coupled
receptor CXCR2 [53] and potentially plays role in
tumor-associated angiogenesis in non-small cell lung
cancer [54]. Its overexpression has been described in
melanoma [55] and in CRC on mRNA level with well-
correlating immunohistochemical results [56, 57]. In 2015,
le Rolle and colleagues found that CXCL1 overexpression
is a poor prognostic marker on metastatic CRC, further-
more, CXCL1 inhibition could suppress tumor cell growth
of KRAS mutant CRC cells [58]. On the basis of Oladipo
and collaborators’ immunohistochemistry results of CRCFFPE samples (n = 254), CXCL1 protein level was sig-
nificantly elevated in tumor tissue samples compared
to normal adjacent tissue samples [59]. Matrix-
metalloproteinase-3 (MMP3) is highly expressed in
colorectal carcinomas [60], the encoded protein plays
role in tumor invasion, lymph node involvement and
metastatic spread [61].
Conclusion
Automated nucleic isolation protocols can hold possi-
bilities in gene expression studies due to the fact, that
several samples can be processed in parallel in a
highly standardized manner with minimal hands-on
time. With the MagNA Pure 96 system high RNA
amounts could be isolated from biopsies as well as
from FFPE tissue slides. Although the quality of the
FFPE samples were found to be lower compared to
the fresh frozen material, in combination with pre-
optimized short amplicon sized assays, this sample
type could also serve similar results as fresh frozen
biopsy samples. The set could discriminate between
normal colonic and CRC FFPE samples with 96.7 %
sensitivity and 70.0 % specificity. According to our
results, gene expression analysis of the analyzed
colorectal cancer-specific marker set can be per-
formed from FFPE tissue material. With the addition
of an automated workflow, this marker set may en-
hance the objective classification of colorectal neo-
plasias in the routine procedure.
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